Therapeutic Management

One of the main aims of treatment in T2D is to reduce the risk of vascular complications. Glucose control helps to reduce microvascular complications, but its impact on macrovascular outcomes remains uncertain. Patients with T2D may therefore require additional CV risk factor control.